Bronchiectasis Market is Expected to Surge at a CAGR of 15% by 2036, Owing to the Launch of DPP1/CatC Inhibitors, Therapeutic Phage Cocktails, Nebulized Mucoactive Agents, and Other Novel Mechanisms | DelveInsight

Summary

Market analysis report predicts the bronchiectasis market will grow at 15% CAGR through 2036, driven by emerging therapies including DPP1/CatC inhibitors, therapeutic phage cocktails, and nebulized mucoactive agents.